Neumora Therapeutics, Inc. · NASDAQ:NMRA

Raymond Debbane reported a 5.40% stake in Neumora Therapeutics, Inc. (Schedule 13G)

Event Feb 13, 2026 · Filed Feb 19, 2026

Raymond Debbane reported a 5.40% stake in Neumora Therapeutics, Inc., 8,997,822 shares, as a passive investor on Feb 13, 2026. Filed Feb 19, 2026 (Schedule 13G).

Stake
5.40%
Shares
8,997,822
Intent
Passive
What changed
Crossed above 5%
Filed together
8 holders

The filing in full

HolderStakeShares
Invus Public Equities, L.P.4.90%8,172,814
Invus Public Equities Advisors, LLC4.90%8,172,814
Invus Global Management, LLC4.90%8,172,814
Siren, L.L.C.4.90%8,172,814
Avicenna Life Sci Master Fund LP0.50%825,008
Avicenna Life Sci Master GP LLC0.50%825,008
Ulys, L.L.C.0.50%825,008
Raymond Debbane5.40%8,997,822

Source

View original at SEC

Related